Table 2.
Symptoms, neurological conditions, comorbidities and ASA score
| Symptoms/neurological conditions and comorbidities | All patients | Group I (age: ≤ 64 yrs) | Group II (age: ≥ 65 yrs) | Subgroup IIa (age: 65–69 yrs) | Subgroup IIb (age: 70–79 yrs) | Subgroup IIc (age: ≥ 80 yrs) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | |
| Symptoms/neurological conditions | ||||||||||||
| Cranial nerve disorder | 237 | 30.9 | 171 | 35.3 | 66 | 23.2 | 25 | 24.8 | 30 | 20.8 | 11 | 26.8 |
| Headache | 229 | 29.8 | 168 | 34.7 | 61 | 21.5 | 26 | 25.7 | 31 | 21.5 | 4 | 9.8 |
| Gait disorder and dizziness | 148 | 19.3 | 73 | 15.1 | 75 | 26.4 | 24 | 23.8 | 37 | 25.7 | 15 | 36.6 |
| Seizure | 106 | 13.8 | 66 | 13.6 | 40 | 14.1 | 10 | 9.9 | 20 | 13.9 | 10 | 24.4 |
| Personality change and memory disorder | 104 | 13.5 | 49 | 10.1 | 55 | 19.4 | 17 | 16.8 | 27 | 18.8 | 11 | 26.8 |
| Palsy | 62 | 8.1 | 28 | 5.8 | 34 | 12 | 5 | 5 | 21 | 14.6 | 8 | 19.5 |
| Sensitive disorder | 45 | 5.9 | 29 | 6 | 16 | 5.6 | 4 | 4 | 11 | 7.6 | 1 | 2.4 |
| Speech disorder | 43 | 5.6 | 20 | 4.1 | 23 | 8.1 | 9 | 8.6 | 8 | 5.6 | 6 | 14.6 |
| Swelling | 34 | 4.4 | 30 | 6.2 | 4 | 1.4 | 1 | 1 | 3 | 2.1 | – | – |
| Olfactory dysfunction | 28 | 3.6 | 17 | 3.5 | 11 | 3.9 | 6 | 5.9 | 5 | 3.5 | – | – |
| Hormonal disorder | 5 | 0.7 | 5 | 1 | – | – | – | – | – | – | – | – |
| Comorbidities | ||||||||||||
| Arterial hypertension | 323 | 42.1 | 147 | 30.4 | 176 | 62 | 48 | 47.5 | 97 | 67.4 | 33 | 80.5 |
| Heart failure/arrhythmia | 74 | 9.6 | 18 | 3.7 | 56 | 19.7 | 12 | 11.9 | 30 | 20.8 | 14 | 34.1 |
| Heart anomaly | 23 | 3 | 9 | 1.9 | 14 | 4.9 | 4 | 4 | 6 | 4.2 | 4 | 9.8 |
| Diabetes mellitus | 74 | 9.6 | 31 | 6.4 | 43 | 15.1 | 13 | 12.9 | 26 | 18.1 | 5 | 12.2 |
| COPD/asthma | 48 | 6.3 | 21 | 4.3 | 27 | 9.5 | 4 | 4 | 19 | 13.2 | 4 | 9.8 |
| Any cancers | 115 | 15 | 60 | 12.4 | 55 | 19.4 | 13 | 12.9 | 30 | 20.8 | 12 | 29.3 |
| Renal failure | 23 | 3 | 8 | 1.7 | 15 | 5.3 | 2 | 2 | 9 | 6.3 | 4 | 9.8 |
| Endocrine disease | 120 | 15.6 | 73 | 15.1 | 47 | 16.5 | 10 | 9.9 | 30 | 20.8 | 8 | 19.5 |
| Depression | 32 | 4.2 | 28 | 5.8 | 4 | 1.4 | 2 | 2 | 2 | 1.4 | – | – |
| Neurosurgical intervention | 32 | 4.2 | 19 | 3.9 | 13 | 4.6 | 7 | 6.9 | 4 | 2.8 | 2 | 4.9 |
| Other diseasesa | 286 | 37.2 | 147 | 30.4 | 139 | 48.9 | 42 | 41.6 | 72 | 50 | 26 | 63.4 |
| No comorbidity | 210 | 27.3 | 173 | 35.7 | 37 | 13 | 20 | 19.8 | 16 | 11.1 | 1 | 2.4 |
| Anticoagulant | 102 | 13.3 | 26 | 5.4 | 76 | 26.8 | 20 | 19.8 | 44 | 30.6 | 13 | 32.7 |
| ASA score | ||||||||||||
| 1 | 114 | 14.8 | 95 | 19.6 | 19 | 6.7 | 7 | 6.9 | 12 | 8.3 | – | – |
| 2 | 435 | 56.6 | 304 | 62.8 | 131 | 46.1 | 57 | 56.4 | 59 | 41 | 17 | 41.5 |
| 3 | 191 | 24.9 | 69 | 14.3 | 122 | 43 | 35 | 34.7 | 66 | 45.8 | 21 | 51.2 |
| 4 | 16 | 2.1 | 8 | 1.7 | 8 | 2.8 | – | – | 5 | 3.5 | 3 | 7.3 |
| 5 | 2 | 0.3 | 2 | 0.4 | – | – | – | – | – | – | – | – |
yrs years
aOther diseases represent different diseases, such as allergies, peripheral arterial disease, musculoskeletal diseases and different surgical interventions